miR-182, as previously mentioned, figures as an oncogenic miRNA by targeting its downstream gene FBXW7 in BC, capable of accelerating HIF-1α/VEGF-A-induced angiogenesis under hypoxia condition (93). Here, HIF1A is linked to breast cancer.